As of Nov 20, 2026, 2 of 2 active firms rate HURA a Buy (0 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
HURA EPS & revenue forecast
EPS · NEXT QUARTER
$-0.15
Range $-0.15 – $-0.15 · 2 analysts · +15% YoY
Next period, 2 analysts expect TuHURA Biosciences Inc to earn $-0.15 a share (range $-0.15 – $-0.15), versus $-0.13 a year earlier. Full-year consensus is $-0.49, growing to $-0.63 the year after.
REVENUE · NEXT QUARTER
$0
Range $0 – $0 · 2 analysts
Revenue is expected to reach $0 (range $0 – $0). Full-year consensus is $0, rising to $0 next year.
Top analysts covering TuHURA Biosciences Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on HURA.
#1
RB
Robert Burns
HC Wainwright & Co. · Rank #215
Buy
$10.00+632.6% to target
Overall win rate
42%
+ Follow
#2
Jason McCarthy
Maxim Group · Rank #567
Buy
$8.00+486.1% to target
Overall win rate
30%
+ Follow
#3
ST
Silvan Turkcan
Citizens
Buy
$9.00+559.3% to target
Coverage
—
+ Follow
#4
MK
Michael King
Rodman & Renshaw
Buy
$7.00+412.8% to target
Coverage
—
+ Follow
#5
KR
Kumaraguru Raja
Brookline Capital Markets
Buy
$9.00+559.3% to target
Coverage
—
+ Follow
HURA stock forecast FAQ
What is HURA's average 12-month price target?+
The 2 active firms with a live target average $9.50 for TuHURA Biosciences Inc over the next 12 months, ranging from a $10.00 high to a $9.00 low, as of Nov 20, 2026.
Is HURA stock a Buy, Sell or Neutral right now?+
The current consensus is Insufficient coverage. Of the 2 active firms as of Nov 20, 2026, 2 rate it Buy or Strong Buy, 0 rate it Neutral, and 0 rate it Sell or Strong Sell.
What are the highest and lowest price targets for HURA?+
The Street-high target is $10.00 (HC Wainwright & Co.), and the Street-low is $9.00 (Citizens). The average of all 2 active-firm targets is $9.50.
How many active Wall Street firms cover HURA?+
2 active firms have a recognized rating on TuHURA Biosciences Inc as of Nov 20, 2026, and 2 active firms carry a live 12-month price target.
Who is the most accurate analyst covering HURA?+
Among analysts who currently cover HURA, Robert Burns of HC Wainwright & Co. has the strongest overall Quantellect track record (Rank #215). Their current call is Buy with a $10.00 target.
What is TuHURA Biosciences Inc's projected EPS for next quarter?+
The consensus estimate is $-0.15 per share (range $-0.15 – $-0.15) across 2 analysts. Full-year EPS is projected at $-0.49, rising to $-0.63 the following year.
How much revenue is TuHURA Biosciences Inc expected to report next quarter?+
Consensus revenue is $0 (range $0 – $0). Full-year revenue is projected at $0, growing to $0 next year.
Have analysts been upgrading or downgrading HURA lately?+
As of Nov 20, 2026, 2 of 2 active firms rate HURA a Buy (0 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their HURA calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.